Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/25/2010EP2220050A2 Diarylhydantoin compounds as androgen receptor modulators
08/25/2010EP2220048A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/25/2010EP2220047A2 Compounds and methods
08/25/2010EP2220046A1 Inhibitors of human immunodeficiency virus replication
08/25/2010EP2220044A1 P38 map kinase inhibitors
08/25/2010EP2220043A1 Crystalline form of an antimalarial compound
08/25/2010EP2220042A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
08/25/2010EP2220040A1 New crystalline diphenyl acetidinone hydrate, pharmaceutical agent containing said compound and use thereof
08/25/2010EP2220036A1 Dioxoanthracene sulphonate derivatives
08/25/2010EP2220033A1 Crystalline forms of tigecycline hydrochloride
08/25/2010EP2220032A1 Novel solvate
08/25/2010EP2220031A1 Polymorphic forms of aliskiren hemifumarate and process for preparation thereof
08/25/2010EP2220030A2 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases
08/25/2010EP2220029A1 Novel compounds
08/25/2010EP2220028A1 Halogenated analogues of anti-fibrotic agents
08/25/2010EP2220027A1 New polymorphic forms of n-ý4-(trifluoromethyl)benzyl¨-4-methoxybutyramide
08/25/2010EP2220026A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase
08/25/2010EP2219736A2 Methods relating to breathing disorders
08/25/2010EP2219680A2 Compounds and methods for modulating protein expression
08/25/2010EP2219655A2 Methods of treating or preventing inflammatory diseases of the intestinal tract
08/25/2010EP2219654A2 Treatment of inflammatory diseases
08/25/2010EP2219652A2 Phospholipid compositions and uses thereof
08/25/2010EP2219651A1 Oral compositions of abt-263 for treating cancer
08/25/2010EP2219650A1 Compositions and methods for treating fibroproliferative disorders
08/25/2010EP2219649A2 Use of mnk inhibitors for the treatment of alzheimer's disease
08/25/2010EP2219648A1 Treatment of post-traumatic stress disorder with tetrahydroindolone arylpiperazine compounds
08/25/2010EP2219647A1 Therapeutic uses of compounds having combined sert, 5-ht3 and 5-ht1a activity
08/25/2010EP2219646A2 Method for altering the lifespan of eukaryotic organisms
08/25/2010EP2219644A2 Solid compositions
08/25/2010EP2219642A1 Silibinin component for the treatment of hepatitis
08/25/2010EP2219641A1 Compositions containing flavanoid polyphenol derivatives, and applications thereof in controlling diseases and ageing of living organisms
08/25/2010EP2219640A2 Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same
08/25/2010EP2219638A2 Lipoxin a4 protection for retinal cells
08/25/2010EP2219637A1 Avenanthramide-containing compositions
08/25/2010EP2219636A2 Reduced sexual maturation in fish
08/25/2010EP2219635A2 Methods of inhibiting bacterial virulence and compounds relating thereto
08/25/2010EP2219634A1 Pharmaceutical for the treatment of phantom phenomena
08/25/2010EP2219632A1 Composition for the treatment of hypertrophic scars comprising fucose, dimethylsulfone and/or acetyl glucosamine
08/25/2010EP2219631A1 Use of anti-bacterial compounds having an anaesthetic effect
08/25/2010EP2219629A1 Novel compounds as cannabinoid receptor ligands
08/25/2010EP2219628A1 Means and methods for treating or preventing brain tumors based on the nuclear receptor tailless (tlx)
08/25/2010EP2219627A2 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction
08/25/2010EP2219625A1 Drug-containing nanoparticles
08/25/2010EP2219622A1 Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
08/25/2010EP2219619A1 Disulfide chemotherapeutic agents and methods of use thereof
08/25/2010EP2219618A2 Pharmaceutical formulations for the oral administration of ppi
08/25/2010EP2219617A1 Pharmaceutical composition comprising at least one active agent and a binder, which swells in an acidic media
08/25/2010EP2219616A2 Lyophilized pharmaceutical composition with improved stability containing taxane derivatives, and method of manufacturing the same
08/25/2010EP2219615A2 Improved pharmaceutical dry powder compositions for inhalation
08/25/2010EP2219614A1 Pharmaceutical composition of orlistat
08/25/2010EP2219611A1 Pharmaceutical forms for the release of active compounds
08/25/2010EP2219610A2 Compositions containing capsaicinoids
08/25/2010EP2219603A1 Transdermal delivery system
08/25/2010EP2219601A2 Non-aqueous water-miscible materials as vehicles for drug delivery
08/25/2010EP2219599A2 Clonidine formulations in a biodegradable polymer carrier
08/25/2010EP2219595A1 Polysaccharide gel formulation
08/25/2010EP2219587A1 Sterol-modified amphiphilic lipids
08/25/2010EP2219554A1 Progesterone-containing compositions and devices
08/25/2010EP2219546A1 Endoscopic mucosal resectioning using purified inverse thermosensitive polymers
08/25/2010EP2219477A1 Composition for regulating lipid metabolism
08/25/2010EP2219453A1 Quinoxaline-containing compounds as hepatitis c virus inhibitors
08/25/2010EP2219451A1 Method for treating hematopoietic neoplasms
08/25/2010EP2219450A1 Alleviating neuropathic pain with eets and seh inhibitors
08/25/2010EP2219449A1 Methods for treating visceral pain
08/25/2010EP2219448A1 Therapeutic compounds and their use in treating diseases and disorders
08/25/2010EP2219447A2 S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
08/25/2010EP2219446A2 Compositions of s-alkylisothiouronium derivatives for treating upper respiratory congestion
08/25/2010EP2094265B1 Pyrroloy[1,2-a]imidazoledione effective in the treatment of peripheral neurotoxicity induced by chemotherapeutic agents
08/25/2010EP2069302B1 Substituted pyridylmethyl bicyclocarboxyamide compounds
08/25/2010EP2051981B1 1h-furo[3,2-c] pyrazole compounds useful as kinase inhibitors
08/25/2010EP2047855B1 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants)
08/25/2010EP2032562B1 Selective inhibitors of rock protein kinase and uses thereof
08/25/2010EP1994030B1 Multi-cyclic compounds and method of use
08/25/2010EP1987033B1 Diazabicycloalkane derivatives and their medical use
08/25/2010EP1966184B1 Pyridinyl-quinazoline derivatives and their medical use
08/25/2010EP1931641B1 NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES COMPOUNDS AS CYCLIN DEPENDENT KINASE INHI
08/25/2010EP1910338B1 Heterotetracyclic compounds as tpo mimetics
08/25/2010EP1879884B1 Azole-based phosphodiesterase inhibitors
08/25/2010EP1871758B1 Aminoalkyl-amidomethyl-substituted 2- (4-sulphonylamino) -3-hydroxy-3 , 4-dihydro-2h-cromen-6-yl derivatives and their use as potassium channel blockers
08/25/2010EP1807434B1 Thienopyridines as allosteric potentiators of the m4 muscarinic receptor
08/25/2010EP1778676B1 Hydantoin derivatives for the treatment of inflammatory disorders
08/25/2010EP1742912B1 Novel androgens
08/25/2010EP1716132B1 Spiro-benzodioxoles and their use as cb1 antagonists
08/25/2010EP1658302B1 Purine nucleoside analogues for treating diseases caused by flaviviridae including hepatitis c
08/25/2010EP1648465B1 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability
08/25/2010EP1641792B1 Pyrrolodihydroisoquinolines as pde10 inhibitors
08/25/2010EP1638940B1 Pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
08/25/2010EP1637531B1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
08/25/2010EP1620082B9 Medical use of inhibitors of glutaminyl and glutamate cyclases for treating alzheimer's disease and down syndrome
08/25/2010EP1591443B1 Pyrazole derivative
08/25/2010EP1551834B1 Substituted quinazolinone compounds
08/25/2010EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
08/25/2010EP1482791B1 Antimicrobial therapeutic compositions and methods of use
08/25/2010EP1481679B1 Antidepressant
08/25/2010EP1480627B1 Methods of reducing angiogenesis
08/25/2010EP1474109B1 Use of synthetic inorganic nanoparticles as carriers for ophthalmic drugs
08/25/2010EP1385857B1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
08/25/2010EP1366016B1 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
08/25/2010EP1363632B1 Receptor selective cannabimimetic aminoalkylindoles
08/25/2010EP1339402B1 Azaphenanthridone derivatives and their use as parp inhibitors
1 ... 2120 2121 2122 2123 2124 2125 2126 2127 2128 2129 2130 2131 2132 2133 2134 2135 2136 2137 2138 2139 2140 ... 7860